Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • lre1234
    Senior Member
    • Aug 2011
    • 110

    #1

    Help resolve a lab debate...

    Hi all,
    We are having a lab debate regarding short RNA sequence. Specifically, we generally we do unique mapping of the reads to the genome. After intersecting the mapped reads to the miRNAs and other short RNAs we want to calculate a RPM value. My lab mate wants to normalize the expression to the total number of raw reads (total off of the machine). Me, on the other hand thinks that we should be normailzing to the total number of mapped reads.

    Can someone possible way in on this...
  • dpryan
    Devon Ryan
    • Jul 2011
    • 3478

    #2
    You're both wrong, you should normalize all of the samples together using a more robust statistic (e.g., TMM), rather than something problematic like RPM.

    However, if you must use RPM for some reason, then the correct method would be to use the total number of aligned reads. You don't want differences in alignment rate to change your metrics (though you should pay attention to these for quality control purposes).

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
      by SEQadmin2



      Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

      Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
      ...
      Today, 09:55 AM
    • SEQadmin2
      New Genomics Technologies Take Aim at Long-Standing Limits
      by SEQadmin2


      Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

      We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
      ...
      09-28-2026, 10:25 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, Today, 05:39 AM
    0 responses
    10 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, Yesterday, 09:56 AM
    0 responses
    11 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-09-2026, 11:14 AM
    0 responses
    25 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 09-29-2026, 09:51 AM
    0 responses
    77 views
    0 reactions
    Last Post SEQadmin2  
    Working...